3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and Asthma

3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole has been researched along with Asthma in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kardos, P	1
Chen, HN; Chen, SC; Chin, YY; Chu, YT; Hung, CH; Kuo, CH; Lam, KP; Lee, MS; Tok, TS; Wang, WL	1
Boulet, LP; Bousquet, J; Carlsheimer, A; Magnussen, H; Martinez-Aguilar, NE; Peters, MJ; Quiralte, J	1

Trials

2 trial(s) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and Asthma

Article	Year
Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study. Pneumologie (Stuttgart, Germany), 2013, Volume: 67, Issue:8 Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Germany; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Self Administration; Serotonin; Treatment Outcome	2013
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. Respiratory medicine, 2007, Volume: 101, Issue:12 Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Hospitalization; Humans; Lung; Male; Middle Aged; Proportional Hazards Models; Respiratory Function Tests; Serotonin; Treatment Outcome	2007

Article

Year

Budesonide/formoterol maintenance and reliever therapy versus free-combination therapy for asthma: a real-life study.

Pneumologie (Stuttgart, Germany), 2013, Volume: 67, Issue:8

Topics: Administration, Inhalation; Adrenal Cortex Hormones; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Drug Therapy, Combination; Ethanolamines; Female; Formoterol Fumarate; Germany; Humans; Male; Middle Aged; Prevalence; Quality of Life; Risk Factors; Self Administration; Serotonin; Treatment Outcome

2013

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.

Respiratory medicine, 2007, Volume: 101, Issue:12

Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Azides; Budesonide; Child; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Ethanolamines; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Hospitalization; Humans; Lung; Male; Middle Aged; Proportional Hazards Models; Respiratory Function Tests; Serotonin; Treatment Outcome

2007

Other Studies

1 other study(ies) available for 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole and Asthma

Article	Year
Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2011, Volume: 22, Issue:4 Topics: Albuterol; Asthma; Azides; Bronchi; Cell Line; Chemokine CCL5; Chemokine CXCL10; Cyclic AMP; Epithelial Cells; Fenoterol; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Poly I-C; Propanolamines; Serotonin	2011

Article

Year

Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2011, Volume: 22, Issue:4

Topics: Albuterol; Asthma; Azides; Bronchi; Cell Line; Chemokine CCL5; Chemokine CXCL10; Cyclic AMP; Epithelial Cells; Fenoterol; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Poly I-C; Propanolamines; Serotonin

2011